¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"ischemic encephalopathy"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • acute necrotizing hemorrhagic encephalopathy
    ±Þ¼º±«»çÃâÇ÷³úº´(Áõ)
  • bilirubin encephalopathy
    ºô¸®·çºó³úº´(Áõ)
  • demyelinating encephalopathy
    ¸»ÀÌÁýÅ»¶ô³úº´(Áõ), Å»¼öÃʳúº´(Áõ)
  • encephalopathy
    ³úº´(Áõ)
  • hypertensive encephalopathy
    °íÇ÷¾Ð³úº´(Áõ)
  • hypoglycemic encephalopathy
    ÀúÇ÷´ç³úº´(Áõ)
  • hypoxic encephalopathy
    Àú»ê¼Ò³úº´(Áõ)
  • lead encephalopathy
    ³³Áßµ¶³úº´(Áõ)
  • necrotizing encephalopathy
    ±«»ç³úº´(Áõ)
  • portal-systemic encephalopathy
    ¹®¸ÆÀü½Å¼øÈ¯(¼º)³úº´(Áõ)
  • progressive subcortical encephalopathy
    ÁøÇà°ÑÁú¹Ø³úº´(Áõ), ÁøÇàÇÇÁúÇϳúº´(Áõ)
  • saturnine encephalopathy
    ³³Áßµ¶³úº´(Áõ)
  • spongiform encephalopathy
    ÇØ¸é¸ð¾ç³úº´(Áõ), °¹¼ØÇü³úº´(Áõ)
  • uremic encephalopathy
    ¿äµ¶³úº´(Áõ)
  • Wernicke encephalopathy
    º£¸£´ÏÄɳúº´(Áõ)
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • anoxic encephalopathy
    ¹«»ê¼Ò³úº´Áõ
  • bilirubin encephalopathy
    ºô¸®·çºó³úº´Áõ
  • demyelinating encephalopathy
    ¸»ÀÌÁýÅ»¶ô³úº´Áõ
  • encephalopathy
    ³úº´Áõ
  • hyperglycemic encephalopathy
    °ú´ÙÇ÷´ç³úº´Áõ
  • hypertensive encephalopathy
    °íÇ÷¾Ð³úº´Áõ
  • hypoglycemic encephalopathy
    ÀúÇ÷´ç³úº´Áõ
  • hypoxic encephalopathy
    Àú»ê¼Ò³úº´Áõ
  • necrotizing encephalopathy
    ±«»ç³úº´Áõ
  • portal-systemic encephalopathy
    ¹®¸ÆÀü½Å¼øÈ¯³úº´Áõ
  • posttraumatic encephalopathy
    ¿Ü»óÈijúº´Áõ
  • progressive subcortical encephalopathy
    ÁøÇà°ÑÁú¹Ø³úº´Áõ
  • saturnine encephalopathy
    ³³Áßµ¶³úº´Áõ
  • spongiform encephalopathy
    °¹¼ØÇü³úº´Áõ, ÇØ¸é³úº´Áõ
  • traumatic encephalopathy
    ¿Ü»ó³úº´Áõ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • hypoxic encephalopathy
    Àú»ê¼Ò¼º³úº´Áõ(î¸ß«áÈàõÒàÜ»ñø)
  • posttraumatic encephalopathy
    ¿Ü»óÈÄ ³úÁõ,¿Ü»óÈÄ ³úº´º¯
  • progressive subcortical encephalopathy
    ÁøÇ༺ ÇÇÁúÇϳúÀå¾Ö<³úÁõ>(¡­ù«òõù» Òàî¡äô<Òàñø>).
  • progressive subcortical encephalopathy
    ÁøÇ༺ ÇÇÁúÇϳúÀå¾Ö<³úÁõ>(òäú¼àõ ù«òõù»Òàî¡äô<Òàñø>)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • ischemic heart disease
    ÇãÇ÷¼º ½ÉÁúȯ
  • ischemic heart disease
    ÇãÇ÷¼º ½ÉÁúȯ(¡­ãýòðü´)
  • ischemic heart disease =IHD
    ÇãÇ÷¼º ½ÉÁúȯ(¡­ãýòðü´).
  • ischemic heart disease,angina pectoris
    Çù½ÉÁõ(úõãýñø)
  • ischemic heart disease,hyperlipidemia
    °íÁöÇ÷Áõ(ÍÔò·úìñø)
  • ischemic heart disease,sudden cardiac death
    ±Þ¼º ½ÉÀå»ç(Ðáàõ ãýíó
  • ischemic hypoxia
    ÇãÇ÷¼º Àú»ê¼ÒÁõ (¡­î¸ß«áÈñø).
  • ischemic interval
    ÇãÇ÷½Ã°£(¡­ãÁÊà).
  • ischemic kidney
    ÇãÇ÷½Å(¡­ãì).
  • ischemic lumbago
    ÇãÇ÷¼º ¿äÅë(¡­é¦÷Ô).
  • ischemic neuritis
    ÇãÇ÷¼º ½Å°æ¿°.
  • ischemic oculopathy
    ÇãÇ÷¾Èº´Áõ
  • ischemic optic atrophy
    ÇãÇ÷½Ã½Å°æÀ§Ãà
  • ischemic optic neuropathy
    ÇãÇ÷½Ã½Å°æº´Áõ
  • ischemic paralysis
    ÇãÇ÷¼º ¸¶ºñ.
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
ACE acetonitrile; acetylcholine esterase; acute cerebral encephalopathy; acute coronary event; adrenocor...
ADEE age-dependent epileptic encephalopathy
ATE acute toxic encephalopathy; adipose tissue extract; autologous tumor extract
BSE behavior summarized evaluation; bilateral intranasal sphenoethmoiclectomy; bilateral symmetrical and...
DE deprived eye; diagnostic error; dialysis encephalopathy; digestive energy; dose equivalent; dream el...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
IVD Ischemic vascular dementia
NAION nonarteric anterior ischemic optic neuropathy
PI Post ischemic
RIND REVERSIBLE ISCHEMIC NEUROLOGICAL DEFICIT
RIA Reversible Ischemic Attacks
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
alcoholic encephalopathy <neurology> Encephalopathy associated with thiamin deficiency. Usually associated with chronic alcohol abuse. Other features include loss of memory and confabulation.
Origin: Gr. Pathos = disease
(27 Sep 1997)
bilirubin encephalopathy <paediatrics> Disorder due to jaundice in a newborn baby with high blood levels of the pigment bilirubin that is deposited in the brain resulting in damage. The level of bilirubin is monitored in newborns to determine whether treatment is needed to prevent kernicterus. With brain affected, it is also called bilirubin encephalopathy.
(12 Dec 1998)
Binswanger's encephalopathy One of the causes of multiinfarct dementia, in which there are many infarcts and lacunes in the white matter, with relative sparing of the cortex and basal ganglia.
Synonym: Binswanger's encephalopathy, encephalitis subcorticalis chronica, subcortical arteriosclerotic encephalopathy.
(05 Mar 2000)
bovine spongiform encephalopathy A new disease of cattle, first reported in 1986 in Great Britain, characterised clinically by apprehensive behaviour, hyperesthesia, and ataxia and histopathologically by spongiform changes in the gray-matter neuropil of the brain stem; it is thought to be caused by an agent, possibly a prion, similar to that observed as the cause of scrapie.
Synonym: mad cow disease.
(05 Mar 2000)
palindromic encephalopathy A relatively mild form which tends to recur.
(05 Mar 2000)
pancreatic encephalopathy A metabolic encephalopathy associated with extensive pancreatic necrosis.
(05 Mar 2000)
recurrent encephalopathy A progressive form of encephalopathy occurring in young members of the same family; characterised by headache, vertigo, truncal ataxia, drowsiness and stupor, speech impairments, choreic-athetoid movements, and sometimes convulsions.
(05 Mar 2000)
metabolic encephalopathy Encephalopathy characterised by memory loss, vertigo, and generalised weakness, due to metabolic brain disease including hypoxia, ischemia, hypoglycaemia, or secondary to other organ failure such as liver or kidney.
(05 Mar 2000)
Wernicke-Korsakoff encephalopathy See: Wernicke's syndrome, Korsakoff's syndrome.
(05 Mar 2000)
Wernicke's encephalopathy <neurology> Encephalopathy associated with thiamin deficiency. Usually associated with chronic alcohol abuse. Other features include loss of memory and confabulation.
Origin: Gr. Pathos = disease
(27 Sep 1997)
portal-systemic encephalopathy An encephalopathy associated with cirrhosis of the liver, attributed to the passage of toxic nitrogenous substances from the portal to the systemic circulation; cerebral manifestations may include coma.
Synonym: hepatic encephalopathy.
(05 Mar 2000)
progressive subcortical encephalopathy <radiology> Demyelinating disease due to papovavirus, seen in immunosuppressed hosts: lymphoma, leukaemia, AIDS, TB, sarcoidosis, organ transplant, most prominent in pareito-occipital white matter, NO contrast enhancement
(12 Dec 1998)
hepatic encephalopathy <neurology, pathology> A condition which is used to describe the deleterious effects of liver failure on the central nervous system. Features include confusion ranging to unresponsiveness (coma). A common cause is alcoholic cirrhosis.
Treatment includes the binding and elimination of ammonia in the intestinal tract. General life support including respiratory support and cardiovascular support may also be required.
See: encephalopathy for additional details.
(27 Sep 1997)
saturnine encephalopathy A metabolic encephalopathy, caused by the ingestion of lead compounds and seen particularly in early childhood; it is characterised pathologically by extensive cerebral oedema, status spongiosus, neurocytolysis, and some reactive inflammation; clinical manifestations include convulsions, delirium, and hallucinations.
See: lead poisoning.
Synonym: lead encephalitis, saturnine encephalopathy.
(05 Mar 2000)
HIV encephalopathy <immunology> A frequent cerebral condition in people with AIDS that results in the loss of cognitive capacity, affecting the ability to function in a social or occupational setting.
Its cause has not been determined exactly, but may result from HIV infection of cells in the brain or an inflammatory reaction to such infection.
(09 Oct 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á